⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17904152 | 0.97 | INMT (0.39) | — | |
| Iodide SCHEMBL28973917 | 0.97 | — | — | |
| SCHEMBL16204305 | 0.97 | INMT (0.39) | — | |
| SCHEMBL17297100 | 0.97 | INMT (0.39) | — | |
| SCHEMBL16020841 | 0.97 | INMT (0.39) | — | |
| SCHEMBL15090048 | 0.97 | INMT (0.39) | — | |
| SCHEMBL9945743 | 0.97 | — | — | |
| SCHEMBL266971 | 0.92 | — | — | |
| SCHEMBL12256345 | 0.76 | — | — | |
| SCHEMBL26791451 | 0.73 | INMT (0.39) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 51 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240025887-A1 | THIENYL AND CYCLOALKYL AMINOPYRIMIDINE COMPOUNDS AS INHIBITORS OF NUAK KINASES, COMPOSITIONS AND USES THEREOF | SINAI HEALTH SYSTEM (CA) | 2024-01-25 | — | — | US | disclosed |
| US-11753492-B2 | Acryloyl based polymers with active end cap as corrosion inhibitors | SAUDI ARABIAN OIL COMPANY (SA) | 2023-09-12 | — | — | US | disclosed |
| US-20230265096-A1 | APOL1 INHIBITORS AND METHODS OF USE | HERCULES CAPITAL, INC., AS AGENT | 2023-08-24 | — | — | US | disclosed |
| US-20230167221-A1 | COPOLYMERS OF (3-ACRYLAMIDOPROPYL)TRIMETHYL AMMONIUM CHLORIDE AS CORROSION INHIBITOR INTERMEDIATE | SAUDI ARABIAN OIL COMPANY (SA) | 2023-06-01 | — | — | US | disclosed |
| CN-115845934-A | One-dimensional rigid all-carbon skeleton arylene polymer anion exchange membrane and preparation method thereof | 中国科学院青岛生物能源与过程研究所 | 2023-03-28 | — | — | CN | disclosed |
| CN-109476606-B | Benzosultams and analogs and their use as fungicides | 拜耳作物科学股份公司 | 2023-01-20 | — | — | CN | disclosed |
| WO-2022078407-A1 | HETEROCYCLIC GLP-1 AGONISTS | GASHERBRUM BIO, INC. (US) | 2022-04-21 | — | — | WO | disclosed |
| US-20220033417-A1 | THERAPEUTIC AGENTS AND USES THEREOF | ANKH LIFE SCIENCES LIMITED (IE) | 2022-02-03 | — | — | US | disclosed |
| WO-2020156106-A1 | HETEROCYCLIC ARYL FORMAMIDES OR SALT THEREOF, PREPARATION METHOD, WEEDING COMPOSITION, AND APPLICATION | 青岛清原化合物有限公司 | 2020-08-06 | — | — | WO | disclosed |
| US-10590076-B2 | Hepatitis B capsid assembly modulators | VenatoRx Pharmaceuticals, Inc. (US) | 2020-03-17 | — | — | US | disclosed |
| US-7655804-B2 | N-[(1S)-3-{(2Z)-2-[(4R)-3,4-dimethyl-1,3-thiazolidin-2-ylidene]hydrazino}-2,3-dioxo-1-(tetrahydro-2H-pyran-4-yl)propyl]cycloheptanecarboxamide; cysteine protease inhibitors; for the treatment of inflammatory, immune, ischemic, respiratory,circulatory, neuronal, blood, hepatic and metabolic diseases | ONO PHARMACEUTICAL CO., LTD. (JP) | 2010-02-02 | — | — | US | disclosed |
| US-20090197834-A1 | QUINOLONE DERIVATIVE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF | ASTELLAS PHARMA INC. (JP) | 2009-08-06 | — | — | US | disclosed |
| US-20090197834-A1 | QUINOLONE DERIVATIVE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF | ASTELLAS PHARMA INC. (JP) | 2009-08-06 | — | — | US | disclosed |
| EP-1995240-A1 | QUINOLONE DERIVATIVE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF | Astellas Pharma Inc. (JP) | 2008-11-26 | — | — | EP | disclosed |
| US-20080139811-A1 | RETROVIRAL PROTEASE INHIBITING COMPOUNDS | ABBVIE INC. | 2008-06-12 | — | — | US | disclosed |
| US-20080009490-A1 | Hiv Integrase Inhibitors | MERCK SHARP & DOHME CORP. | 2008-01-10 | — | — | US | disclosed |
| US-4353913-A | ANTHELMINTICS | BAYER AKTIENGESELLSCHAFT (DE) | 1982-10-12 | — | — | US | disclosed |
| EP-0010242-B1 | BENZIMIDAZOLYL-2-CARBAMIC ACID ESTERS, MEDICAMENTS BASED THEREON AND PROCESS FOR THEIR PREPARATION | BAYER AG (DE) | 1982-09-29 | — | — | EP | disclosed |
| US-4287199-A | USEFUL AS ANTHELMINITICS | BAYER AKTIENGESELLSCHAFT (DE) | 1981-09-01 | — | — | US | disclosed |
| EP-0010242-A1 | Benzimidazolyl-2-carbamic acid esters, medicaments based thereon and process for their preparation | BAYER AG (DE) | 1980-04-30 | — | — | EP | disclosed |